Originally published May 3, 2007 at 12:00 AM | Page modified May 3, 2007 at 2:01 AM
Report touts new drug to fight osteoporosis
A yearly 15-minute infusion of a new drug substantially reduces bone fractures in post-menopausal women, offering a new treatment option...
Los Angeles Times
A yearly 15-minute infusion of a new drug substantially reduces bone fractures in post-menopausal women, offering a new treatment option for women who have trouble taking existing bone-strengthening drugs, researchers reported today.
Although drugs such as Fosamax and Actonel are effective at preventing bone loss and reducing the major health risks associated with fractures, as many as half of women stop taking them within six months because of the complicated regimen required and the risk of side effects.
The new drug, zoledronic acid, "requires an encounter with the medical establishment only once a year, so there is no problem with compliance and adherence," said Dr. Robert Recker of the Creighton University School of Medicine in Nebraska.
The drug also avoids the esophageal problems that are common with the oral drugs, said Recker, who is vice president of the National Osteoporosis Foundation and was not involved in the study.
The three-year study of 7,736 post-menopausal women found a 70 percent reduction in the risk of spinal fractures and a 40 percent reduction in the risk of hip fractures.
"But even more remarkable were the strong, significant and consistent effects across all fracture types," said epidemiologist Dennis Black of the University of California, San Francisco School of Medicine, who led the study.
The results were "impressive," wrote Dr. Juliet Compston of the University of Cambridge School of Clinical Medicine in Britain in an editorial accompanying the report in The New England Journal of Medicine.
The drug is sold by drug maker Novartis in the U.S. under the brand name Zometa to treat Paget's disease — a genetic disorder in which bone becomes soft and breaks down readily — and the prevention of bone loss in cancer chemotherapy. The company is applying to the Food and Drug Administration to sell it under the name Reclast for treating osteoporosis.
About 10 million people in the U.S. suffer from osteoporosis, and an additional 34 million have low bone density, which puts them at risk for the disorder, according to the osteoporosis foundation.
Copyright © 2007 The Seattle Times Company
UPDATE - 09:38 PM
New General Motors expected to exit Chapter 11
Jobless claims indicate economy remains weak
Tough fight coming up in Afghanistan, Petraeus says in Seattle
UPDATE - 08:47 PM
Worst violence since US pullback hits Iraq
Afghan blast kills 25, half of them children

Gen. David Petraeus: Iraq and Afghanistan Wars
Watch highlights of General David Petraeus discussing the Iraq and Afghanistan War at the Global Leadership Series sponsored by the World Affairs Council.
Entertainment | Top Video | World | Offbeat Video | Sci-Tech
shopping

events for Thursday, Jul. 9th
- REI Summer Sale and Clearance
- Karan Dannenberg Clothier Progressive...
- Queen Anne Farmers Market
- Kibbn Storewide Summer Sale
editors' picks
More shopping guides- Key lawmakers warn of Boeing no-strike ultimatum
- Seattle-area homebuilder losing projects to foreclosure
- Hemmed-in Ballard house to rise above
- Health-plan costs soar for individuals
- Drunken man shocks Spain with his generosity
- UW Football | Tailbacks David Freeman, Brandon Johnson ineligible
- Trees vs. houses: Narrow, leafy street is last chance for two Madrona homes waiting to be moved
- World's largest solar plant may be built in Cle Elum
- Experts work to untangle US, Korea cyber attack
- Nickels gives City Light chief $40,000 bonus
- Mass. files lawsuit against federal marriage law
913 - Health-plan costs soar for individuals
513 - Texas Rangers at Seattle Mariners: 07/09 game thread
243 - Teen charged in pit bull attacks ordered held after pleading not guilty
150 - World's largest solar plant may be built in Cle Elum
122 - Trees vs. houses: Narrow, leafy street is last chance for two Madrona homes waiting to be moved
91 - Wednesday night notes
86 - Pay parking in West Seattle?
76 - Franklin Gutierrez bails Mariners out in a 3-1 win
69 - House Dems want to expand secret briefings
63
- Seattle-area homebuilder losing projects to foreclosure
- Hemmed-in Ballard house to rise above
- Key lawmakers warn of Boeing no-strike ultimatum
- Health-plan costs soar for individuals
- World's largest solar plant may be built in Cle Elum
- Rick Steves' Europe | Beware of new and classic travel scams
- Happy Hour | Ruth's Chris has super rib-eye sliders and quality cocktails
- Trees vs. houses: Narrow, leafy street is last chance for two Madrona homes waiting to be moved
- Grab the kids and hop on Amtrak for a stress-free getaway to Portland
- All You Can Eat | "Top Chef": Seattle chefs tapped for Bravo knife fight in Vegas!
